About us
News
Nordic Pharma Announces CE Mark Approval for Lacrifill® Canalicular Gel, Paving the Way for European Launch
-
Hoofddorp, Netherlands, April 9th 2025 – Nordic Group B.V., an…
Company news
Nordic Pharma Announces CE Mark Approval for Lacrifill® Canalicular Gel, Paving the Way for European Launch
Hoofddorp, Netherlands, April 9th 2025 – Nordic Group B.V., an international...
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), CONTINUES ITS INTRODUCTION OF LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, DURING AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) 2024.
-
Nordic Pharma to share this innovation and its pivotal study…
Company news
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), CONTINUES ITS INTRODUCTION OF LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE, DURING AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) 2024.
Nordic Pharma to share this innovation and its pivotal study article...
NORDIMET (methotrexate) Self-Injection Pen now available for Treatment of Rheumatoid Arthritis and Psoriasis/Psoriatic Arthritis in Canada
-
Press Release Toronto, August 5, 2024 – Linepharma International Inc.,…
Company news
NORDIMET (methotrexate) Self-Injection Pen now available for Treatment of Rheumatoid Arthritis and Psoriasis/Psoriatic Arthritis in Canada
Press Release Toronto, August 5, 2024 – Linepharma International Inc., a...
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES THE LAUNCH OF LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE.
-
Nordic Pharma attending Kiawah Eye to share this innovation with…
Company news
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), ANNOUNCES THE LAUNCH OF LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR DRY EYE.
Nordic Pharma attending Kiawah Eye to share this innovation with ophthalmology...
Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership
-
Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic…
Company news
Amring Pharmaceuticals Inc. Announces Name Change to Nordic Pharma, Inc. Under New Nordic Group, B.V. Ownership
Amring Pharmaceuticals Inc. (“Amring”) announces its name change to Nordic Pharma,...
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY AMRING PHARMACEUTICALS INC., ANNOUNCES JAI G. PAREKH, MD, MBA AS CHIEF COMMERCIAL OFFICER, EYE CARE U.S.
-
BERWYN, PA — Amring Pharmaceuticals Inc. (Amring), a subsidiary of…
Company news
NORDIC GROUP B.V. THROUGH ITS SUBSIDIARY AMRING PHARMACEUTICALS INC., ANNOUNCES JAI G. PAREKH, MD, MBA AS CHIEF COMMERCIAL OFFICER, EYE CARE U.S.
BERWYN, PA -- Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic...
NORDIC PHARMA GROUP B.V. THROUGH ITS SUBSIDIARY AMRING PHARMACEUTICALS INC., COMPLETES ACQUISITION OF VISANT MEDICAL TO LAUNCH NOVEL THERAPY FOR DRY EYE DISEASE IN THE UNITED STATES
-
BERWYN, PA — Amring Pharmaceuticals Inc. (Amring), a subsidiary of…
Company news
NORDIC PHARMA GROUP B.V. THROUGH ITS SUBSIDIARY AMRING PHARMACEUTICALS INC., COMPLETES ACQUISITION OF VISANT MEDICAL TO LAUNCH NOVEL THERAPY FOR DRY EYE DISEASE IN THE UNITED STATES
BERWYN, PA -- Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic...
Nordic Pharma joins the Pharmaceutical Supply Chain Initiative
-
We are pleased to announce that Nordic Pharma has joined…
Company news
Nordic Pharma joins the Pharmaceutical Supply Chain Initiative
We are pleased to announce that Nordic Pharma has joined the...
Draupnir Holdings Ltd have officially merged with Nordic Group B.V
-
We are pleased to announce that as of January 2023,…
Company news
Draupnir Holdings Ltd have officially merged with Nordic Group B.V
We are pleased to announce that as of January 2023, Draupnir...
Nordic Pharma files submission to health Canada for the marketing authorization of methotrexate autoinjector for treating rheumatoid arthritis in Canada
-
Canada, March 29, 2022 – NORDIC PHARMA, a SEVER Life…
Company news
Nordic Pharma files submission to health Canada for the marketing authorization of methotrexate autoinjector for treating rheumatoid arthritis in Canada
Canada, March 29, 2022 - NORDIC PHARMA, a SEVER Life Sciences...
Nordic Pharma has acquired ALTIM® (cortivazol) pre-filled syringe to strengthen their Rheumatology portfolio
-
Paris, January 2022 – Nordic Pharma is pleased to announce…
Product acquisition
Nordic Pharma has acquired ALTIM® (cortivazol) pre-filled syringe to strengthen their Rheumatology portfolio
Paris, January 2022 – Nordic Pharma is pleased to announce that...
European Commission approves Teysuno in metastatic colorectal cancer
-
Nordic Pharma announces that on the 24th of January, the…
Company news
European Commission approves Teysuno in metastatic colorectal cancer
Nordic Pharma announces that on the 24th of January, the European...
Positive EMA opinion for the use of Teysuno in metastatic colorectal cancer
-
Nordic Pharma has announced that on 16 December 2021, the…
Company news
Positive EMA opinion for the use of Teysuno in metastatic colorectal cancer
Nordic Pharma has announced that on 16 December 2021, the Committee...
Nordic Pharma present at CPhI !
-
Nordic Pharma will be attending CPhI Worldwide in Milan, Italy from November…
Company news
Nordic Pharma present at CPhI !
Nordic Pharma will be attending CPhI Worldwide in Milan, Italy from November 9th-11th...
Nordixate® Methotrexate Pre-filled Syringe approved in Colombia
-
Nordic Pharma AAP is pleased to announce that the Nordixate®…
Product launch
Nordixate® Methotrexate Pre-filled Syringe approved in Colombia
Nordic Pharma AAP is pleased to announce that the Nordixate® Methotrexate...
About Our Portfolio